USA 2026
NEUVIOR USA 2026.
Founder Varun Sharma will be in Miami, Los Angeles and New York during 2026. NEUVIOR is arranging selected meetings about medicines, responsible AI, supply resilience, pharmaceutical infrastructure and commercial collaboration.
Travel confirmed | Exact dates and meetings stay privateWhat NEUVIOR wants to learn
How do US operators make these decisions in practice?
Medicines supply, adoption, AI and investment decisions work differently across the United States, the United Kingdom, India and Europe. NEUVIOR wants to compare the real workflow, where responsibility sits and which problems are worth pursuing.
Medicines
Implementation, access, supply resilience and accountable follow through.
Responsible AI
Human authority, decision records, false confidence, infrastructure control and safe exit.
Company building
Pharmaceutical infrastructure, partnership fit and market discovery rooted in evidence.
From Varun
I want the conversations that are usually avoided.
What is actually broken? Who can decide? Which part is worth fixing? Bring me a real medicines, AI, investment, media or brand question. If the answer is no, I would rather know quickly.
Miami | Los Angeles | New York
Why these three cities.
The route is set. Exact dates stay private so each stop can be shaped around worthwhile conversations instead of a public diary.
Miami
Life sciences, healthcare, capital, founder networks and connections across the Americas, the United Kingdom and India.
USA 2026Los Angeles
Biotechnology, research, health systems, responsible technology, media, design and brand worlds.
USA 2026New York
Medicines, capital, major institutions, enterprise technology and global media in one concentrated ecosystem.
USA 2026Who NEUVIOR wants to hear from
If you own one of these decisions, talk to us.
A useful meeting starts with a specific issue, the person who can act and a reason to discuss it now. Varun will bring a direct view, relevant UK and India context and an honest answer on whether a next step makes sense.
- 01
Pharma and health
A live implementation, access, supply or governance question with someone able to act on it.
- 02
Research and technology
A source, method, infrastructure capability or responsible AI question worth testing.
- 03
Capital and strategy
An investment or market thesis with the evidence and uncomfortable assumptions visible.
- 04
Media and events
A real editorial question, a defined audience, a format and a deadline.
- 05
Brands and culture
A creative idea with a clear audience, rights position and commercial frame.
The public boundary
The trip is confirmed. Outcomes are not.
This page confirms 2026 travel to Miami, Los Angeles and New York. It does not announce a US office, public event, customer, partner, investor commitment, fundraising result, regulatory status or deployment.
Exact flights, hotels, private meetings and movement details will stay private. Invitations are reviewed for relevance and scheduling happens directly.
USA 2026 | Pick the city
What makes a useful conversation.
Choose a city. The topics change, but the standard does not. There should be a real question and a reason to act.Health, capital, founder networks and business across the Americas.
One medicines, health, investment or partnership question with a person who can act on it.
Varun's direct view, relevant UK and India context and a clear answer on whether to continue.
Biotechnology, responsible technology, media, design and cultural reach.
A serious idea that connects science, systems, media or brand.
A direct discussion of fit, reputation, delivery and whether a small first project makes sense.
Medicines, institutions, enterprise technology, capital and global media.
A decision, thesis, story or operating problem and the evidence behind it.
A structured review of the evidence, the opportunity and what should happen next.
Questions and boundaries
Useful questions before we start.
01Is the USA trip confirmed?
Yes. Varun Sharma will be in Miami, Los Angeles and New York during 2026. Exact dates and private movement details are shared only where a relevant meeting is being arranged.
02Is NEUVIOR opening a US office?
No US office, facility, customer, event, partnership, deployment or regulatory status is announced by this page.
03Who should request a conversation?
Pharma and biotechnology operators, medicines and health system leaders, responsible AI researchers, data or delivery partners, healthcare investors, journalists, programme hosts and selective brands with a defined topic.
04What should an enquiry include?
Organisation, role, preferred city, conversation category, one decision or problem that can be described without confidential information, the intended outcome and broad availability.
USA 2026
Which city should we meet in?
Share your organisation, role, city, decision, intended outcome and broad availability. Keep the first message free of confidential information.